Koninklijke Philips (PHG) Long-Term Debt Issuances (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Long-Term Debt Issuances came in at $11.7 million in Q1 2026, up 23.67% year-on-year from $9.5 million in Q1 2025, and up 101.0% quarter-over-quarter from -$1.2 billion in Q4 2025.
Koninklijke Philips (PHG) Long-Term Debt Issuances (2009 - 2026) Analysis & Trends
Koninklijke Philips' Long-Term Debt Issuances history runs 18 years deep, the most recent figure standing at $11.7 million for Q1 2026.
- On a quarterly basis, Long-Term Debt Issuances rose 23.67% year-over-year to $11.7 million in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 53.19% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 62.17% from the prior year.
- Long-Term Debt Issuances grew to $11.7 million in Q1 2026 per PHG's latest filing, from -$1.2 billion in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $2.1 billion in Q2 2022 and bottomed at -$1.2 billion in Q4 2025.
- The 5-year median for Long-Term Debt Issuances is $35.9 million (2023), against an average of $379.6 million.
- Across the five-year window, Long-Term Debt Issuances soared 6483.1% in 2022 and tumbled 98.32% in 2023, its largest moves.
- Year by year, Long-Term Debt Issuances stood at $2.1 billion in 2022, then tumbled by 98.32% to $35.9 million in 2023, then plunged by 2160.8% to -$740.5 million in 2024, then tumbled by 57.66% to -$1.2 billion in 2025, then surged by 101.0% to $11.7 million in 2026.
- Per Business Quant, the three latest PHG Long-Term Debt Issuances figures stand at $11.7 million (Q1 2026), -$1.2 billion (Q4 2025), and $1.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.71 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.71 Mn |
| Mar 31, 2026 | 11.71 Mn |
| Dec 31, 2025 | -1.17 Bn |
| Dec 31, 2025 | -1.17 Bn |
| Sep 30, 2025 | 1.22 Bn |
| Sep 30, 2025 | 1.22 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Mar 31, 2025 | 9.47 Mn |
| Mar 31, 2025 | 9.47 Mn |
| Dec 31, 2024 | -740.54 Mn |
| Dec 31, 2024 | -740.54 Mn |
| Sep 30, 2024 | 774.24 Mn |
| Sep 30, 2024 | 774.24 Mn |
| Jun 30, 2024 | 743.05 Mn |
| Jun 30, 2024 | 743.05 Mn |
| Mar 31, 2024 | 8.69 Mn |
| Mar 31, 2024 | 8.69 Mn |
| Jun 30, 2023 | 35.93 Mn |
| Jun 30, 2023 | 35.93 Mn |